AMA Backs Structured Vaccine Review - Takeaways - MDSpire

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

  • By

  • Kathryn Wighton

  • February 11, 2026

  • 4 min

Share

  • 1

    The AMA and Vaccine Integrity Project launched an initiative to assess vaccine safety and effectiveness for the 2026-2027 season.

  • 2

    This initiative aims to create a formal process for evaluating scientific evidence supporting respiratory virus vaccinations.

  • 3

    The review process will include expert panels, systematic literature reviews, and public protocols for data transparency.

  • 4

    The AMA's involvement marks a shift towards prioritizing public health evidence in vaccine recommendations.

  • 5

    The initiative seeks to restore confidence in vaccines through continuous evaluation and credible evidence for clinicians.

Original Source(s)

AMA Backs Structured Vaccine Review

  • by Kathryn Wighton

  • February 11, 2026

Related Content

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

HPV Chatbots Did Not Outperform Public Materials

Brief GPT-4o chatbot conversations increased parents' HPV vaccination intentions immediately following exposure, but public health materials showed more durable effects, and no intervention increased self-reported vaccination uptake.

Pathogen effects on the brain: the case of SARS-CoV-2 spike protein and neuro COVID